Cargando…

Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies

OBJECTIVES: To analyze the clinical characteristics, echocardiographic features, and prognosis of fetuses based on three groups of cardiac manifestations associated with maternal anti-Ro and anti-La antibodies in China. This study included three groups: the isolated-arrhythmia, isolated-endocardial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Liu, Xiao-wei, Han, Ling, Li, Meng-tao, Zhao, Jiu-liang, Sun, Lin, Han, Jian-cheng, Zeng, Xiao-feng, Tian, Xin-ping, Zhao, Ying, He, Yi-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371606/
https://www.ncbi.nlm.nih.gov/pubmed/35967560
http://dx.doi.org/10.3389/fped.2022.904138
_version_ 1784767193090621440
author Wang, Xin
Liu, Xiao-wei
Han, Ling
Li, Meng-tao
Zhao, Jiu-liang
Sun, Lin
Han, Jian-cheng
Zeng, Xiao-feng
Tian, Xin-ping
Zhao, Ying
He, Yi-hua
author_facet Wang, Xin
Liu, Xiao-wei
Han, Ling
Li, Meng-tao
Zhao, Jiu-liang
Sun, Lin
Han, Jian-cheng
Zeng, Xiao-feng
Tian, Xin-ping
Zhao, Ying
He, Yi-hua
author_sort Wang, Xin
collection PubMed
description OBJECTIVES: To analyze the clinical characteristics, echocardiographic features, and prognosis of fetuses based on three groups of cardiac manifestations associated with maternal anti-Ro and anti-La antibodies in China. This study included three groups: the isolated-arrhythmia, isolated-endocardial fibroelastosis (EFE), and mixed groups. METHODS: We prospectively evaluated 36 fetuses with cardiac manifestations due to maternal anti-Ro and anti-La antibodies from our center between 2016 and 2020 in China. Clinical and echocardiographic data were collected. RESULTS: There were 13 patients (36%) in the isolated-arrhythmia group, eight (22%) in the isolated-EFE group, and 15 (42%) in the mixed group. All patients in the isolated-EFE group presented with mild EFE. Severe EFE was identified in four patients (27%) in the mixed group. Atrioventricular block (AVB) was more common in the isolated-arrhythmia group (13, 100%) than in the mixed group (6, 40%; p = 0.001). Moderate-severe mitral regurgitation (p = 0.006), dilated cardiomyopathy (DCM, p = 0.017), and low cardiovascular profile scores (p = 0.013) were more common in the mixed group than in the other two groups. Twenty-one mothers decided to terminate the pregnancy and 15 fetuses were born with regular perinatal treatment. They all survived at 1 year of age. One patient in the isolated-arrhythmia group and two in the mixed group required a pacemaker due to third-degree AVB or atrioventricular junctional rhythm. Five patients in the isolated-EFE group and five in the mixed group had no DCM or heart failure and the location of mild EFE was significantly reduced. CONCLUSION: Fetal cardiac manifestations due to maternal anti-Ro and anti-La antibodies can be divided into three groups, i.e., the isolated-arrhythmia, isolated-EFE, and mixed groups. AVB usually occurs in the isolated-arrhythmia group. Severe EFE, moderate-severe mitral regurgitation, and DCM mainly appear in the mixed group. Location of mild EFE significantly reduces after birth and the outcome of fetuses with mild EFE depends on the presence of arrhythmia and its subtypes.
format Online
Article
Text
id pubmed-9371606
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93716062022-08-12 Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies Wang, Xin Liu, Xiao-wei Han, Ling Li, Meng-tao Zhao, Jiu-liang Sun, Lin Han, Jian-cheng Zeng, Xiao-feng Tian, Xin-ping Zhao, Ying He, Yi-hua Front Pediatr Pediatrics OBJECTIVES: To analyze the clinical characteristics, echocardiographic features, and prognosis of fetuses based on three groups of cardiac manifestations associated with maternal anti-Ro and anti-La antibodies in China. This study included three groups: the isolated-arrhythmia, isolated-endocardial fibroelastosis (EFE), and mixed groups. METHODS: We prospectively evaluated 36 fetuses with cardiac manifestations due to maternal anti-Ro and anti-La antibodies from our center between 2016 and 2020 in China. Clinical and echocardiographic data were collected. RESULTS: There were 13 patients (36%) in the isolated-arrhythmia group, eight (22%) in the isolated-EFE group, and 15 (42%) in the mixed group. All patients in the isolated-EFE group presented with mild EFE. Severe EFE was identified in four patients (27%) in the mixed group. Atrioventricular block (AVB) was more common in the isolated-arrhythmia group (13, 100%) than in the mixed group (6, 40%; p = 0.001). Moderate-severe mitral regurgitation (p = 0.006), dilated cardiomyopathy (DCM, p = 0.017), and low cardiovascular profile scores (p = 0.013) were more common in the mixed group than in the other two groups. Twenty-one mothers decided to terminate the pregnancy and 15 fetuses were born with regular perinatal treatment. They all survived at 1 year of age. One patient in the isolated-arrhythmia group and two in the mixed group required a pacemaker due to third-degree AVB or atrioventricular junctional rhythm. Five patients in the isolated-EFE group and five in the mixed group had no DCM or heart failure and the location of mild EFE was significantly reduced. CONCLUSION: Fetal cardiac manifestations due to maternal anti-Ro and anti-La antibodies can be divided into three groups, i.e., the isolated-arrhythmia, isolated-EFE, and mixed groups. AVB usually occurs in the isolated-arrhythmia group. Severe EFE, moderate-severe mitral regurgitation, and DCM mainly appear in the mixed group. Location of mild EFE significantly reduces after birth and the outcome of fetuses with mild EFE depends on the presence of arrhythmia and its subtypes. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9371606/ /pubmed/35967560 http://dx.doi.org/10.3389/fped.2022.904138 Text en Copyright © 2022 Wang, Liu, Han, Li, Zhao, Sun, Han, Zeng, Tian, Zhao and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Wang, Xin
Liu, Xiao-wei
Han, Ling
Li, Meng-tao
Zhao, Jiu-liang
Sun, Lin
Han, Jian-cheng
Zeng, Xiao-feng
Tian, Xin-ping
Zhao, Ying
He, Yi-hua
Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies
title Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies
title_full Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies
title_fullStr Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies
title_full_unstemmed Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies
title_short Cardiac manifestations in a Chinese cohort of fetuses from mothers with anti-Ro and anti-La antibodies
title_sort cardiac manifestations in a chinese cohort of fetuses from mothers with anti-ro and anti-la antibodies
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371606/
https://www.ncbi.nlm.nih.gov/pubmed/35967560
http://dx.doi.org/10.3389/fped.2022.904138
work_keys_str_mv AT wangxin cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT liuxiaowei cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT hanling cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT limengtao cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT zhaojiuliang cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT sunlin cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT hanjiancheng cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT zengxiaofeng cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT tianxinping cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT zhaoying cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies
AT heyihua cardiacmanifestationsinachinesecohortoffetusesfrommotherswithantiroandantilaantibodies